Zapanta, John Bryle, and Charity Gorospe. “Efficacy of a Single-Agent Ts1 (Tegafur, Gimeracil, and Oteracil) in Recurrent Gastric Cancer After Progression from Previous Oxaliplatin, Irinotecan, and Anti-Her2 Targeted Therapy: A Case Report”. Asian Pacific Journal of Cancer Care 10, no. 3 (July 14, 2025): 989-992. Accessed July 16, 2025. http://www.waocp.com/journal/index.php/apjcc/article/view/1534.